US generic price erosion and market share loss
UNIM lost market share in two major US products due to increased competition and lower prices, impacting volumes and margins.
IPCALAB / Q2-FY26 / risks
Keep the risk register visible.
IPCA Laboratories · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
GST rationalization impact on domestic business
September GST rate changes caused a temporary disruption in domestic sales, with recovery seen in October.
UNIM synergy realization delayed
Cross-selling benefits from UNIM dossier filings will take 12-18 months for approvals, with margin improvement expected only in 1.5-2 years.
Bulk API order lumpiness
A large European API order boosted Q2 but may not recur in Q3, leading to lower sequential API growth.